Accelerated aging phenotype in mice with conditional deficiency for mitochondrial superoxide dismutase in the connective tissue

Aging Cell

Volumn 10, Issue 2, 2011, Pages 239-254

  Treiber, Nicolai ^a   Maity, Pallab ^a   Singh, Karmveer ^a   Kohn, Matthias ^a   Keist, Alexander F ^a   Ferchiu, Florentina ^a   Sante, Lea ^a   Frese, Sebastian ^b   Bloch, Wilhelm ^b   Kreppel, Florian ^a   Kochanek, Stefan ^a   Sindrilaru, Anca ^a   Iben, Sebastian ^a   Högel, Josef ^a   Ohnmacht, Michael ^a   Claes, Lutz E ^a   Ignatius, Anita ^a   Chung, Jin H ^c   Lee, Min J ^c   Kamenisch, York ^d   Berneburg, Mark ^d   Nikolaus, Thorsten ^e   Braunstein, Kerstin ^a   Sperfeld, Anne Dorte ^a   Ludolph, Albert C ^a,e   Briviba, Karlis ^f   Wlaschek, Meinhard ^a   Scharffetter Kochanek, Karin ^a,e   more..

^a UNIVERSITY OF ULM   (Germany)

^b GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

^c Seoul National University Hospital   (South Korea)

^d UNIVERSITY OF TÜBINGEN   (Germany)

^e Competence Center for Gerontology and Aging Research ^*  (Germany)

^f FEDERAL RESEARCH INSTITUTE OF NUTRITION AND FOOD   (Germany)

Author keywords

Aging; Connective tissue; Mitochondria; P16INK4a; Reactive oxygen species; Sod2

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; MANGANESE SUPEROXIDE DISMUTASE;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL AGING; CONNECTIVE TISSUE; CONTROLLED STUDY; DETOXIFICATION; ENZYME DEFICIENCY; FEMALE; KYPHOSIS; LIFESPAN; MALE; MITOCHONDRION; MOUSE; MUSCLE ATROPHY; NONHUMAN; OSTEOPOROSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SKIN ATROPHY; WEIGHT REDUCTION;

AGING; ANIMALS; BIOLOGICAL MARKERS; BONE AND BONES; CELLS, CULTURED; CONNECTIVE TISSUE; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; FIBROBLASTS; HUMANS; KYPHOSIS; LONGEVITY; MALE; MICE; MICE, KNOCKOUT; MITOCHONDRIA; MUSCLE, SKELETAL; PHENOTYPE; REACTIVE OXYGEN SPECIES; SKIN; SUPEROXIDE DISMUTASE; SUPEROXIDES;

MUS;

EID: 79952599163     PISSN: 14749718     EISSN: 14749726     Source Type: Journal    
DOI: 10.1111/j.1474-9726.2010.00658.x     Document Type: Article

References (79)

1. Allen RG, Tresini M, Keogh BP, Doggett DL, Cristofalo VJ (1999) Differences in electron transport potential, antioxidant defenses, and oxidant generation in young and senescent fetal lung fibroblasts (WI-38). J. Cell. Physiol. 180, 114-122.
2. Belousov VV, Fradkov AF, Lukyanov KA, Staroverov DB, Shakhbazov KS, Terskikh AV, Lukyanov S (2006) Genetically encoded fluorescent indicator for intracellular hydrogen peroxide. Nat. Methods 3, 281-286.
3. Bodine PV, Billiard J, Moran RA, Ponce-de-Leon H, McLarney S, Mangine A, Scrimo MJ, Bhat RA, Stauffer B, Green J, Stein GS, Lian JB, Komm BS (2005) The Wnt antagonist secreted frizzled-related protein-1 controls osteoblast and osteocyte apoptosis. J. Cell. Biochem. 96, 1212-1230.
4. Brooke MH, Engel WK (1969) The histographic analysis of human muscle biopsies with regard to fiber types. 2. Diseases of the upper and lower motor neuron. Neurology 19, 378-393.
5. Brooks SV, Faulkner JA (1988) Contractile properties of skeletal muscles from young, adult and aged mice. J. Physiol. 404, 71-82.
6. Campisi J (2005) Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 120, 513-522.
7. Coppe JP, Patil CK, Rodier F, Sun Y, Munoz DP, Goldstein J, Nelson PS, Desprez PY, Campisi J (2008) Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 6, 2853-2868.
8. Cummings SR, Melton LJ (2002) Epidemiology and outcomes of osteoporotic fractures. Lancet 359, 1761-1767.
9. Dai CY, Enders GH (2000) p16 INK4a can initiate an autonomous senescence program. Oncogene 19, 1613-1622.
10. Ferrari SL, Deutsch S, Choudhury U, Chevalley T, Bonjour JP, Dermitzakis ET, Rizzoli R, Antonarakis SE (2004) Polymorphisms in the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with variation in vertebral bone mass, vertebral bone size, and stature in whites. Am. J. Hum. Genet. 74, 866-875.
11. Fisher AL (2004) Of worms and women: sarcopenia and its role in disability and mortality. J. Am. Geriatr. Soc. 52, 1185-1190.
12. Fisher GJ, Varani J, Voorhees JJ (2008) Looking older: fibroblast collapse and therapeutic implications. Arch. Dermatol. 144, 666-672.
13. Florin L, Alter H, Grone HJ, Szabowski A, Schutz G, Angel P (2004) Cre recombinase-mediated gene targeting of mesenchymal cells. Genesis 38, 139-144.
14. Garinis GA (2008) Nucleotide excision repair deficiencies and the somatotropic axis in aging. Hormones (Athens) 7, 9-16.
15. Garinis GA, van der Horst GT, Vijg J, Hoeijmakers JH (2008) DNA damage and ageing: new-age ideas for an age-old problem. Nat. Cell Biol. 10, 1241-1247.
16. Gerhard GS, Kasales CJ (2003) Aging and kyphosis. J. Gerontol. A Biol. Sci. Med. Sci. 58, 968.
17. Grillari J, Katinger H, Voglauer R (2007) Contributions of DNA interstrand cross-links to aging of cells and organisms. Nucleic Acids Res. 35, 7566-7576.
18. Haines DC, Chattopadhyay S, Ward JM (2001) Pathology of aging B6;129 mice. Toxicol. Pathol. 29, 653-661.
19. Hiona A, Leeuwenburgh C (2008) The role of mitochondrial DNA mutations in aging and sarcopenia: implications for the mitochondrial vicious cycle theory of aging. Exp. Gerontol. 43, 24-33.
20. Horowitz MC, Lorenzo JA (2007) Immunologic regulation of bone development. Adv. Exp. Med. Biol. 602, 47-56.
21. Huang TT, Naeemuddin M, Elchuri S, Yamaguchi M, Kozy HM, Carlson EJ, Epstein CJ (2006) Genetic modifiers of the phenotype of mice deficient in mitochondrial superoxide dismutase. Hum. Mol. Genet. 15, 1187-1194.
22. Hutter E, Unterluggauer H, Uberall F, Schramek H, Jansen-Durr P (2002) Replicative senescence of human fibroblasts: the role of Ras-dependent signaling and oxidative stress. Exp. Gerontol. 37, 1165-1174.
23. Iannuzzi-Sucich M, Prestwood KM, Kenny AM (2002) Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women. J. Gerontol. A Biol. Sci. Med. Sci. 57, M772-M777.
24. Jang YC, Lustgarten MS, Liu Y, Muller FL, Bhattacharya A, Liang H, Salmon AB, Brooks SV, Larkin L, Hayworth CR, Richardson A, Van Remmen H (2010) Increased superoxide in vivo accelerates age-associated muscle atrophy through mitochondrial dysfunction and neuromuscular junction degeneration. FASEB J. 24, 1376-1390.
25. Kalu DN (1995) Handbook of Physiology: Section 11: Aging: Aging Section 11. In Handbook of Physiology: Section 11: Aging: Aging Section 11 (Handbook of Physiology). USA: Oxford University Press Inc.
26. Kaya G, Tran C, Sorg O, Hotz R, Grand D, Carraux P, Didierjean L, Stamenkovic I, Saurat JH (2006) Hyaluronate fragments reverse skin atrophy by a CD44-dependent mechanism. PLoS Med 3, e493.
27. Kim WY, Sharpless NE (2006) The regulation of INK4/ARF in cancer and aging. Cell 127, 265-275.
28. Kim JV, Kang SS, Dustin ML, McGavern DB (2009) Myelomonocytic cell recruitment causes fatal CNS vascular injury during acute viral meningitis. Nature 457, 191-195.
29. Kops GJ, Dansen TB, Polderman PE, Saarloos I, Wirtz KW, Coffer PJ, Huang TT, Bos JL, Medema RH, Burgering BM (2002) Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature 419, 316-321.
30. Kreppel F, Biermann V, Kochanek S, Schiedner G (2002) A DNA-based method to assay total and infectious particle contents and helper virus contamination in high-capacity adenoviral vector preparations. Hum. Gene Ther. 13, 1151-1156.
31. Krishnamurthy J, Torrice C, Ramsey MR, Kovalev GI, Al-Regaiey K, Su L, Sharpless NE (2004) Ink4a/Arf expression is a biomarker of aging. J. Clin. Invest. 114, 1299-1307.
32. Krishnamurthy J, Ramsey MR, Ligon KL, Torrice C, Koh A, Bonner-Weir S, Sharpless NE (2006) p16INK4a induces an age-dependent decline in islet regenerative potential. Nature 443, 453-457.
33. Krtolica A, Campisi J (2002) Cancer and aging: a model for the cancer promoting effects of the aging stroma. Int. J. Biochem. Cell Biol. 34, 1401-1414.
34. Kushnareva Y, Murphy AN, Andreyev A (2002) Complex I-mediated reactive oxygen species generation: modulation by cytochrome c and NAD(P)+ oxidation-reduction state. Biochem. J. 368, 545-553.
35. Labat-Robert J, Robert L (2007) The effect of cell-matrix interactions and aging on the malignant process. Adv. Cancer Res. 98, 221-259.
36. Larsson L (1978) Morphological and functional characteristics of the ageing skeletal muscle in man. A cross-sectional study. Acta Physiol. Scand. Suppl. 457, 1-36.
37. Lass A, Sohal BH, Weindruch R, Forster MJ, Sohal RS (1998) Caloric restriction prevents age-associated accrual of oxidative damage to mouse skeletal muscle mitochondria. Free Radic. Biol. Med. 25, 1089-1097.
38. Lebovitz RM, Zhang H, Vogel H, Cartwright J Jr, Dionne L, Lu N, Huang S, Matzuk MM (1996) Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. Proc. Natl. Acad. Sci. U S A 93, 9782-9787.
39. Lee SS, Kennedy S, Tolonen AC, Ruvkun G (2003) DAF-16 target genes that control C. elegans life-span and metabolism. Science 300, 644-647.
40. Li Y, Huang TT, Carlson EJ, Melov S, Ursell PC, Olson JL, Noble LJ, Yoshimura MP, Berger C, Chan PH, Wallace DC, Epstein CJ (1995) Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat. Genet. 11, 376-381.
41. Luche H, Weber O, Nageswara Rao T, Blum C, Fehling HJ (2007) Faithful activation of an extra-bright red fluorescent protein in "knock-in" Cre-reporter mice ideally suited for lineage tracing studies. Eur. J. Immunol. 37, 43-53.
42. Ma W, Wlaschek M, Tantcheva-Poor I, Schneider LA, Naderi L, Razi-Wolf Z, Schuller J, Scharffetter-Kochanek K (2001) Chronological ageing and photoageing of the fibroblasts and the dermal connective tissue. Clin. Exp. Dermatol. 26, 592-599.
43. Marzetti E, Lees HA, Wohlgemuth SE, Leeuwenburgh C (2009) Sarcopenia of aging: underlying cellular mechanisms and protection by calorie restriction. Biofactors 35, 28-35.
44. Metter EJ, Talbot LA, Schrager M, Conwit R (2002) Skeletal muscle strength as a predictor of all-cause mortality in healthy men. J. Gerontol. A Biol. Sci. Med. Sci. 57, B359-B365.
45. Molofsky AV, Slutsky SG, Joseph NM, He S, Pardal R, Krishnamurthy J, Sharpless NE, Morrison SJ (2006) Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing. Nature 443, 448-452.
46. Muller FL, Lustgarten MS, Jang Y, Richardson A, Van Remmen H (2007) Trends in oxidative aging theories. Free Radic. Biol. Med. 43, 477-503.
47. Newton-John HF, Morgan DB (1970) The loss of bone with age, osteoporosis, and fractures. Clin. Orthop. Relat. Res. 71, 229-252.
48. Niedernhofer LJ, Garinis GA, Raams A, Lalai AS, Robinson AR, Appeldoorn E, Odijk H, Oostendorp R, Ahmad A, van Leeuwen W, Theil AF, Vermeulen W, van der Horst GT, Meinecke P, Kleijer WJ, Vijg J, Jaspers NG, Hoeijmakers JH (2006) A new progeroid syndrome reveals that genotoxic stress suppresses the somatotroph axis. Nature 444, 1038-1043.
49. Oikarinen A (1994) Aging of the skin connective tissue: how to measure the biochemical and mechanical properties of aging dermis. Photodermatol. Photoimmunol. Photomed. 10, 47-52.
50. Perrini S, Laviola L, Carreira MC, Cignarelli A, Natalicchio A, Giorgino F (2010) The GH/IGF1 axis and signaling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis. J. Endocrinol. 205, 201-210.
51. Petrie HT, Van Ewijk W (2002) Thymus by numbers. Nat. Immunol. 3, 604-605.
52. van der Pluijm I, Garinis GA, Brandt RM, Gorgels TG, Wijnhoven SW, Diderich KE, de Wit J, Mitchell JR, van Oostrom C, Beems R, Niedernhofer LJ, Velasco S, Friedberg EC, Tanaka K, van Steeg H, Hoeijmakers JH, van der Horst GT (2007) Impaired genome maintenance suppresses the growth hormone--insulin-like growth factor 1 axis in mice with Cockayne syndrome. PLoS Biol. 5, e2.
53. Quan T, Shao Y, He T, Voorhees JJ, Fisher GJ (2010) Reduced expression of connective tissue growth factor (CTGF/CCN2) mediates collagen loss in chronologically aged human skin. J. Invest. Dermatol. 130, 415-424.
54. Raisz LG (2005) Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J. Clin. Invest. 115, 3318-3325.
55. Ralston SH, de Crombrugghe B (2006) Genetic regulation of bone mass and susceptibility to osteoporosis. Genes Dev. 20, 2492-2506.
56. Rantanen T, Guralnik JM, Foley D, Masaki K, Leveille S, Curb JD, White L (1999) Midlife hand grip strength as a predictor of old age disability. JAMA 281, 558-560.
57. Ressler S, Bartkova J, Niederegger H, Bartek J, Scharffetter-Kochanek K, Jansen-Durr P, Wlaschek M (2006) p16INK4A is a robust in vivo biomarker of cellular aging in human skin. Aging Cell 5, 379-389.
58. Robinson KM, Janes MS, Pehar M, Monette JS, Ross MF, Hagen TM, Murphy MP, Beckman JS (2006) Selective fluorescent imaging of superoxide in vivo using ethidium-based probes. Proc. Natl. Acad. Sci. U S A 103, 15038-15043.
59. Scharffetter-Kochanek K, Wlaschek M, Brenneisen P, Schauen M, Blaudschun R, Wenk J (1997) UV-induced reactive oxygen species in photocarcinogenesis and photoaging. Biol. Chem. 378, 1247-1257.
60. Schiedner G, Hertel S, Kochanek S (2000) Efficient transformation of primary human amniocytes by E1 functions of Ad5: generation of new cell lines for adenoviral vector production. Hum. Gene Ther. 11, 2105-2116.
61. Shin MH, Rhie GE, Kim YK, Park CH, Cho KH, Kim KH, Eun HC, Chung JH (2005) H2O2 accumulation by catalase reduction changes MAP kinase signaling in aged human skin in vivo. J. Invest. Dermatol. 125, 221-229.
62. Sies H (1986) Biochemistry of Oxidative Stress. Angew. Chem. Int. Ed. Engl. 25, 1058-1071.
63. Sies H (1991) Oxidative Stress: Oxidants and Antioxidants. New York: Academic Press, Inc.
64. Stessman J, Maaravi Y, Hammerman-Rozenberg R, Cohen A, Nemanov L, Gritsenko I, Gruberman N, Ebstein RP (2005) Candidate genes associated with ageing and life expectancy in the Jerusalem longitudinal study. Mech. Ageing Dev. 126, 333-339.
65. Strassburger M, Bloch W, Sulyok S, Schuller J, Keist AF, Schmidt A, Wenk J, Peters T, Wlaschek M, Lenart J, Krieg T, Hafner M, Kumin A, Werner S, Muller W, Scharffetter-Kochanek K (2005) Heterozygous deficiency of manganese superoxide dismutase results in severe lipid peroxidation and spontaneous apoptosis in murine myocardium in vivo. Free Radic. Biol. Med. 38, 1458-1470.
66. Sunderkotter C, Kunz M, Steinbrink K, Meinardus-Hager G, Goebeler M, Bildau H, Sorg C (1993) Resistance of mice to experimental leishmaniasis is associated with more rapid appearance of mature macrophages in vitro and in vivo. J. Immunol. 151, 4891-4901.
67. Szabo C, Ischiropoulos H, Radi R (2007) Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat. Rev. Drug Discov. 6, 662-680.
68. Szulc P, Beck TJ, Marchand F, Delmas PD (2005) Low skeletal muscle mass is associated with poor structural parameters of bone and impaired balance in elderly men--the MINOS study. J. Bone Miner. Res. 20, 721-729.
69. Tasker PN, Albagha OM, Masson CB, Reid DM, Ralston SH (2004) Association between TNFRSF1B polymorphisms and bone mineral density, bone loss and fracture. Osteoporos. Int. 15, 903-908.
70. Treiber N, Peters T, Sindrilaru A, Huber R, Kohn M, Menke A, Briviba K, Kreppel F, Basu A, Maity P, Koller M, Iben S, Wlaschek M, Kochanek S, Scharffetter-Kochanek K (2009) Overexpression of manganese superoxide dismutase in human dermal fibroblasts enhances the contraction of free floating collagen lattice: implications for ageing and hyperplastic scar formation. Arch. Dermatol. Res. 301, 273-287.
71. Usuki F, Yasutake A, Umehara F, Higuchi I (2004) Beneficial effects of mild lifelong dietary restriction on skeletal muscle: prevention of age-related mitochondrial damage, morphological changes, and vulnerability to a chemical toxin. Acta Neuropathol. 108, 1-9.
72. Valenti L, Conte D, Piperno A, Dongiovanni P, Fracanzani AL, Fraquelli M, Vergani A, Gianni C, Carmagnola L, Fargion S (2004) The mitochondrial superoxide dismutase A16V polymorphism in the cardiomyopathy associated with hereditary haemochromatosis. J. Med. Genet. 41, 946-950.
73. Van Remmen H, Jones DP (2009) Current thoughts on the role of mitochondria and free radicals in the biology of aging. J. Gerontol. A Biol. Sci. Med. Sci. 64, 171-174.
74. Van Remmen H, Ikeno Y, Hamilton M, Pahlavani M, Wolf N, Thorpe SR, Alderson NL, Baynes JW, Epstein CJ, Huang TT, Nelson J, Strong R, Richardson A (2003) Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging. Physiol. Genomics 16, 29-37.
75. Wallace DC (2010) Mitochondrial DNA mutations in disease and aging. Environ. Mol. Mutagen. 51, 440-450.
76. Wallace DC, Brown MD, Lott MT (1999) Mitochondrial DNA variation in human evolution and disease. Gene 238, 211-230.
77. Wenk J, Brenneisen P, Wlaschek M, Poswig A, Briviba K, Oberley TD, Scharffetter-Kochanek K (1999) Stable overexpression of manganese superoxide dismutase in mitochondria identifies hydrogen peroxide as a major oxidant in the AP-1-mediated induction of matrix-degrading metalloprotease-1. J. Biol. Chem. 274, 25869-25876.
78. Wenk J, Schuller J, Hinrichs C, Syrovets T, Azoitei N, Podda M, Wlaschek M, Brenneisen P, Schneider LA, Sabiwalsky A, Peters T, Sulyok S, Dissemond J, Schauen M, Krieg T, Wirth T, Simmet T, Scharffetter-Kochanek K (2004) Overexpression of phospholipid-hydroperoxide glutathione peroxidase in human dermal fibroblasts abrogates UVA irradiation-induced expression of interstitial collagenase/matrix metalloproteinase-1 by suppression of phosphatidylcholine hydroperoxide-mediated NFkappaB activation and interleukin-6 release. J. Biol. Chem. 279, 45634-45642.
79. Zofkova I (2003) Pathophysiological and clinical importance of insulin-like growth factor-I with respect to bone metabolism. Physiol. Res. 52, 657-679.